Acquisition

RNS Number : 4066T
Compagnie de Saint-Gobain
03 July 2018
 

PRESS RELEASE

 

July 3, 2018

 

 

Saint-Gobain Signs Agreement to Purchase Hunter Douglas'
North American Ceilings Business

 

 

Saint-Gobain has today entered into an agreement to purchase the North American ceilings business of Hunter Douglas, a leading manufacturer of architectural ceilings with two production sites in Norcross, Georgia and Denver, Colorado. The business reported sales of $36 million in 2017.

 

This acquisition will allow Saint-Gobain to acquire a complete range of innovative aluminum, steel, felt and fiberglass ceiling systems for commercial projects of all types. It is in line with Saint-Gobain's strategy to consolidate its leadership positions and to develop adjacent niches. It will significantly increase the Group's presence in the high-growth architectural specialties market.

 

The pending transaction is subject to customary closing conditions and is expected to be finalized in July 2018.

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€40.8 billion in sales in 2017

Operates in 67 countries

More than 179,000 employees

www.saint-gobain.com 
@saintgobain

 

 

 

Analyst/Investor relations

 

 

Media relations

Vivien Dardel

Floriana Michalowska

Christelle Gannage

+33 1 47 62 44 29

 +33 1 47 62 35 98

 +33 1 47 62 30 93

Laurence Pernot

Susanne Trabitzsch

 +33 1 47 62 30 10

 +33 1 47 62 43 25

       

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQRJMPTMBJMMJP
UK 100